XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.23.2

Balance Sheet Details | 6 Months Ended
--- | ---
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Balance Sheet Details | 5. Balance Sheet Details Inventory consisted of the following (in thousands):
|  | June 30, 2023 |  |  | December 31, 2022 |
Finished goods |  | $ | 2,004 |  |  | $ | 1,926 |
Work in process |  |  | 5,310 |  |  |  | 4,427 |
Raw material |  |  | 6,809 |  |  |  | 5,207 |
|  | $ | 14,123 |  |  | $ | 11,560 |
Reported as: |  |  |  |  |  |
Inventory |  | $ | 9,199 |  |  | $ | 6,636 |
Long-term inventory |  |  | 4,924 |  |  |  | 4,924 |
Total |  | $ | 14,123 |  |  | $ | 11,560 |
Amount reported as long-term inventory consisted of raw materials for NUPLAZID as of June 30, 2023 and December 31, 2022. The Company has raw materials beyond a one year production plan that help limit the exposures from potential supply interruption. Those raw materials beyond the one year production plan were classified as long-term inventory. Accrued liabilities consisted of the following (in thousands):
|  | June 30, 2023 |  |  | December 31, 2022 |
Accrued sales allowances |  | $ | 47,423 |  |  | $ | 26,046 |
Accrued research and development services |  |  | 31,697 |  |  |  | 35,048 |
Accrued contingent payments |  |  | 29,583 |  |  |  | — |
Accrued compensation and benefits |  |  | 25,413 |  |  |  | 28,023 |
Accrued consulting and professional fees |  |  | 12,242 |  |  |  | 11,377 |
Current portion of lease liabilities |  |  | 9,058 |  |  |  | 9,305 |
Current portion of accrued branded prescription drug fees |  |  | 7,828 |  |  |  | 1,060 |
Other |  |  | 5,887 |  |  |  | 2,025 |
|  | $ | 169,131 |  |  | $ | 112,884 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration